Tom Van Maerken

Small-Molecule MDM2 Antagonists as a New Therapy Concept for Neuroblastoma

Tom Van Maerken, Frank Speleman, Joëlle Vermeulen et al. · Cancer Research · 2006 · 159 citations · Full text

Medicine, Oncology, Pharmacology +14

Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer

Liesbeth Ferdinande, Christine Decaestecker, Laurine Verset et al. · British Journal of Cancer · 2011 · 150 citations · Full text

Medicine, Immunology, Oncology +17

An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours

Pieter Mestdagh, Erik Fredlund, Filip Pattyn et al. · Oncogene · 2010 · 146 citations

Medicine, Genetics, Molecular Genetics +16

Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53

Tom Van Maerken, Liesbeth Ferdinande, Jasmien Taildeman et al. · JNCI Journal of the National Cancer Institute · 2009 · 120 citations

Medicine, Oncology, Pharmacology +10

Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma

Hyerin Jeon, Zhao Su, Joanna E. Richards et al. · Oncogene · 2009 · 100 citations

Medicine, Neuroscience, Oncology +12